e-therapeutics to Present at Upcoming Scientific Meetings
London, UK, 03 October 2024 – e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, announced today that it will be presenting at various upcoming scientific conferences.
Oligonucleotide Therapeutics Society (OTS) Annual Meeting (Montreal, Canada)
Title: Discovery and mitigation of side product formation during synthesis of a new GalNAc tether for siRNA conjugation using Strain-promoted azide-alkyne cycloaddition (SPAAC)
Format: Poster Presentation
Date: 6th October 2024
American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2024 (San Diego, CA)
Title: ETX-312 - a GalOmic™ siRNA for the Treatment of MASH
Format: Poster Presentation
Date: 17th November 2024
American Heart Association (AHA) Scientific Sessions 2024 (Chicago, IL)
Title: ETX-258 - A GalOmic™ siRNA for the Treatment of Heart Failure Following Myocardial Infarction
Format: Moderated Digital Poster Presentation
Date: 17th November 2024
Title: ETX-291 - A GalOmic™ siRNA for the Treatment of Cardiometabolic Disease
Format: Moderated Digital Poster Presentation
Date: 18th November 2024